English
Back
Download
Log in to access Online Inquiry
Back to the Top

Insider buy!

$Kymera Therapeutics (KYMR.US)$ Director BVF PARTNERS L P/IL purchased 414.11K shares of Common Stocks on Nov 2, 3, 2023 at an average price of $12.8019 for a total value of $5.3 million.
This transaction involves other related parties: BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL and LAMPERT MARK N.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
9311 Views
Comment
Sign in to post a comment
    5254
    Followers
    23
    Following
    76K
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.